Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Invesque Ord Shs T.IVQ

Alternate Symbol(s):  MHIVF | T.IVQ.DB.U | T.IVQ.DB.V

Invesque Inc. is a health care real estate company. The Company owns a portfolio of North American properties across the health care spectrum. The Company invests in a portfolio of predominantly privately paid senior housing communities. The Company's portfolio includes investments primarily in independent living, assisted living, and memory care, which are operated under long-term leases and joint venture arrangements with industry operating partners. The Company's portfolio also includes investments in owner-occupied seniors housing properties in which the Company owns the real estate, the licensed operations, and provides management services through Commonwealth Senior Living, LLC. It owns a portfolio of over 56 properties in the United States, comprised of 53 assisted living and memory care facilities and three skilled nursing facilities. In Canada, the Company owns an interest in four seniors housing assets.


TSX:IVQ - Post by User

Comment by Capharnaumon Oct 14, 2021 1:12pm
85 Views
Post# 34005856

RE:RE:RE:RE:Value of U debentures

RE:RE:RE:RE:Value of U debentures
2young2invest wrote: I have a feeling that while @Capharnaum is quite convincing he is not toally objective here, as he bought debentures cheap and was expecting to get cash and move on.

I wass expecting the same, but I'm as also a shareholder, so this is NOT big funds shareholders vs small debentureholders as you are trying to make everyone believe.

Indeed, this is shareholders vs debentureholders kind of issue, and being in both camps, I need to choose the smallet from 2 evils.
So far, accepting the deal seems like the smaller evil to me.


Like I've pointed out, I've bought a good number of debentures before the pandemic. In fact, if I hadn't bought as many debentures over $90 as I have and wouldn't face a decent loss due to the offer (around $50k), I would just say f*** this management and move on. All I want is terms that are fair when compared to the convertible debentures issues on the market. No one has come out to justify why a $6 USD conversion price on a $2 USD market price for the conversion rate is fair. It's not like I've been unfair in my posts about IVQ and bashed them. I've given one recent example of another company in a similar position (Chemtrade, conversion rate at 145% of the market) and what Invesque itself had for conversion premium on their debentures (115% of market value and 145% of market value).

Convertible debentures is about 50% of my investments and I've been in various different positions with issues (some worse than IVQ) and the offers that were made (when required) were by far all superior to the one we have here.
<< Previous
Bullboard Posts
Next >>